(Q82638248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Graham K Sheridan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

22 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

382-392

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

Lysolecithin induces demyelination in vitro in a cerebellar slice culture system.

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Sphingosine-1-phosphate and oligodendrocytes: from cell development to the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Sphingosine and sphingosine 1-phosphate differentially modulate platelet-derived growth factor-BB-induced Ca2+ signaling in transformed oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Fingolimod modulates microglial activation to augment markers of remyelination

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Design and synthesis of selective and potent orally active S1P5 agonists.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

FTY720 modulates human oligodendrocyte progenitor process extension and survival.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Microglial activation state and lysophospholipid acid receptor expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Type 1 sphingosine 1-phosphate G protein-coupled receptor (S1P1) mediation of enhanced IL-4 generation by CD4 T cells from S1P1 transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22272

7 January 2021

Identifiers

DOI

10.1002/GLIA.22272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108845%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference